Amicus Therapeutics Inc - Cranbury, New Jersey 08512

Amicus Therapeutics Inc is categorized under in Cranbury, NJ .

Business Name: Amicus Therapeutics Inc
Contact Person: John Crowley, Chief Executive Officer
Address: 1 Cedarbrook Drive, Cranbury, New Jersey 08512
Phone Number: (609) 662-2000
Website Address: amicusrx.com
Annual Revenue (USD): Unknown
Founding Year: 2002
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: The Frederick Purdue Company - Cranbury, NJ 08512
Evenus Pharmaceutical Labs Inc - Cranbury, NJ 08512
Endo Pharmaceuticals Solutions Inc - Cranbury, NJ 08512
Cmic Cmo Usa Corporation - Cranbury, NJ 08512
Purdue Pharma Lp - Cranbury, NJ 08512
Endo Pharmaceuticals Inc - Cranbury, NJ 08512
Sun Pharmaceutical Industries - Cranbury, NJ 08512
Palatin Technologies Inc - Cranbury, NJ 08512
Moore Family Realty Inc - Cranbury, NJ 08512
Kos Pharmaceuticals Inc - Cranbury, NJ 08512
Wyeth LLC - Cranbury, NJ 08512
Cocensys Inc - Cranbury, NJ 08512
Pharmacopeia Inc - Cranbury, NJ 08512
Caraco Pharmaceutical Laboratories Ltd - Cranbury, NJ 08512
P F Laboratories Inc - Cranbury, NJ 08512
Evenus Pharmaceutical Laboratories Inc - Cranbury, NJ 08512

The company Amicus Therapeutics Inc provides BOTH services in the form of from its headquarters in New Jersey. 1 to 4 employees work for Amicus Therapeutics Inc, and the business now earns Unknown per annum.

Amicus Therapeutics Inc was launched in 2002 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Amicus Therapeutics Inc, please call John Crowley, Chief Executive Officer with the phone number (609) 662-2000 or visit its headquarters at 1 Cedarbrook Drive in Cranbury, New Jersey 08512.

The location of the headquarters can also be found using the coordinates 40.33201,-74.50421. Read more details about this business on the webpage amicusrx.com or follow the company’s social media accounts, on Twitter and on Facebook.